For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales growth for its blockbuster obesity drug Wegovy, Doustdar has already ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

From a more company-specific point of view, Pfizer has also agreed to buy Metsera. This will help the company deal with ...